Menstrual Cramps Treatment Market

Reports

📃Pages:
184

📊Tables:
91

📈Charts:
61

🌐Regions/Countries:
4 / 10

🏢Companies:
10

📨Enquiry Hours:
10

Menstrual cramps are pains which cause in lower abdomen and in the back. This is also known as dysmenorrhea. The pain can remain for 2 to 3 days. Chemicals known as prostaglandins are produced by the body which is responsible for most of the symptoms connected with menstrual discomfort. People with more amounts of prostaglandin may experience highly severe uterine contractions and pain. Dysmenorrhea is categorized on the basis of type which includes primary dysmenorrhea and secondary dysmenorrhea. Surge in demand for menstrual cramps treatment because of the increase in cases of menstrual cramps propel the market growth. Apart from this, the rise in government support for healthcare infrastructure developments further fuel the growth of the market. Apart from this, the minimum price of over-the-counter medicines such as ibuprofen leads to growth in demand for menstrual cramps drugs and further accelerates the market growth. However, the less demand for menstrual cramps treatment in under development nations may impede the market growth. The Menstrual Cramps Treatment Market is projected to grow at a rate of 4.0% CAGR by 2027.

Menstrual Cramps Treatment Market by Type:

Primary Dysmenorrhea
Secondary Dysmenorrhea

Menstrual Cramps Treatment Market by Treatment:

Non-steroidal Anti-inflammatory Drugs
Hormonal Therapy

Menstrual Cramps Treatment Market by Distribution Channel:

Hospital Pharmacies
Drug stores and Retail Pharmacies
Online Providers

Menstrual Cramps Treatment Market by Geography:

North America
Europe
Asia Pacific
Rest of the World

The types are bifurcate into Primary Dysmenorrhea and Secondary Dysmenorrhea. The Primary Dysmenorrhea segment is obtaining significant popularity in the market by capturing a highest share in the market. The reason which propels the segment growth is the surge in occurrence of high menstrual bleeding among women and changes in lifestyle, which results in primary dysmenorrhea.

Further on the basis of treatment, the market segmented into Non-steroidal Anti-inflammatory Drugs and Men is can be accredited to the huge sales of medicines from drug stores and retail pharmacies and a surge in patients looking treatment for menstrual cramps.

Geographically, the market is classified into North America, Europe, Asia Pacific and rest of the world. Among them the North America region has captured the maximum share in the market. Owing to the existence of leading vendors in the region, increase in government initiatives as well as well developed healthcare infrastructure in the region the market is growing highly in the region.

Furthermore, the changing lifestyle of people around the world is projected to influence the global market dynamic during the forecast period. Changing lifestyles along with the unhealthy food habits have significant impact on the human body. This further leads to increasing prevalence of dysmenorrhea/ menstrual cramps among women. In addition, the environmental changes are also considered a contributing factor which increases the risk of menstrual cramps.

AbbVie Inc., Torrent Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Johnson and Johnson, Bayer AG, Taj Pharmaceuticals Limited, Abbott Laboratories, Pfizer Inc., and GlaxoSmithKline plc, are some of the competitors that are dominating the market.

Therefore, the women around the world have become more conscious about the menstrual cramps than past now-a-days and the problems regarding the dysmenorrhea are increasing as well. Since, women are seeking for pain relief where menstrual cramps treatments are highly available in the market.

To examine and analyze the market size by key regions, type treatment and distribution channel.
To understand the structure of market by recognizing its various sub segments.
Emphasizes on the key global menstrual cramps treatment competitors, to define, describe and analyze the market competition landscape, market share, value, SWOT analysis and development plans in next few years.
To analyze the market in terms of individual growth trends, future prospects and their contribution to the whole market.

Additional information

User License	Single User, Multi User, Enterprise

Table Of Content

Executive Summary
Industry Outlook
- Industry Overview
- Industry Trends
Market Snapshot
- Market Definition
- Market Outlook
  - Porter Five Forces
- Related Markets
Market characteristics
- Market Overview
- Market Segmentation
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- DRO – Impact Analysis
Type: Market Size & Analysis
- Overview
- Primary Dysmenorrhea
- Secondary Dysmenorrhea
Treatment: Market Size & Analysis
- Overview
- Non-steroidal Anti-inflammatory Drugs
- Hormonal Therapy
Distribution channel: Market Size & Analysis
- Overview
- Hospital pharmacies
- Drug store and retail pharmacies
- Online providers
Geography: Market Size & Analysis
- Overview
- North America
- Europe
- Asia Pacific
- Rest of the World
Competitive Landscape
- Competitor Comparison Analysis
- Market Developments
  - Mergers and Acquisitions, Legal, Awards, Partnerships
  - Product Launches and execution

Vendor Profiles
- AbbVie Inc.
  - Overview
  - Financial Overview
  - Product Offerings
  - Developments
  - Business Strategy
- Torrent Pharmaceuticals Ltd.
  - Overview
  - Financial Overview
  - Product Offerings
  - Developments
  - Business Strategy
- Sun Pharmaceutical Industries Ltd.
  - Overview
  - Financial Overview
  - Product Offerings
  - Developments
  - Business Strategy
- Reddy’s Laboratories Ltd.
  - Overview
  - Financial Overview
  - Product Offerings
  - Developments
  - Business Strategy
- Johnson and Johnson
  - Overview
  - Financial Overview
  - Product Offerings
  - Developments
  - Business Strategy
- Bayer AG
  - Overview
  - Financial Overview
  - Product Offerings
  - Developments
  - Business Strategy
- Taj Pharmaceuticals Limited
  - Overview
  - Financial Overview
  - Product Offerings
  - Developments
  - Business Strategy
- Abbott Laboratories
  - Overview
  - Financial Overview
  - Product Offerings
  - Developments
  - Business Strategy
- Pfizer Inc.
  - Overview
  - Financial Overview
  - Product Offerings
  - Developments
  - Business Strategy
- GlaxoSmithKline plc
  - Overview
  - Financial Overview
  - Product Offerings
  - Developments
  - Business Strategy

Analyst Opinion
Annexure
- Report Scope
- Market Definitions
- Research Methodology
  - Data Collation and In-house Estimation
  - Market Triangulation
  - Forecasting
- Report Assumptions
- Declarations
- Stakeholders
- Abbreviations

Methodology

Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

Data Collation (Primary & Secondary)
In-house Estimation (Based on proprietary data bases and Models)
Market Triangulation
Forecasting

List of Tables

TABLE 1. GLOBAL MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 2. GLOBAL MENSTRUAL CRAMPS TREATMENT MARKET VALUE FOR PRIMARY DYSMENORRHEA, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 3. GLOBAL MENSTRUAL CRAMPS TREATMENT MARKET VALUE FOR SECONDARY DYSMENORRHEA, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 4. GLOBAL MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 5. GLOBAL MENSTRUAL CRAMPS TREATMENT MARKET VALUE FOR NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 6. GLOBAL MENSTRUAL CRAMPS TREATMENT MARKET VALUE FOR HORMONAL THERAPY, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 7. GLOBAL MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 8. GLOBAL MENSTRUAL CRAMPS TREATMENT MARKET VALUE FOR HOSPITAL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 9. GLOBAL MENSTRUAL CRAMPS TREATMENT MARKET VALUE FOR DRUG STORE AND RETAIL PHARMACIES, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 10. GLOBAL MENSTRUAL CRAMPS TREATMENT MARKET VALUE FOR ONLINE PROVIDERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 11. NORTH AMERICA MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 12. NORTH AMERICA MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 13. NORTH AMERICA MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION)

TABLE 14. NORTH AMERICA MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 15. U.S MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 16. U.S MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION)

TABLE 17. U.S MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 18. CANADA MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 19. CANADA MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION)

TABLE 20. CANADA MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 21. EUROPE MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 22. EUROPE MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 23. EUROPE MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION)

TABLE 24. EUROPE MENSTRUAL CRAMPS TREATMENT MARKET VALUE, DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 25. GERMANY MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 26. GERMANY MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION)

TABLE 27. GERMANY MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 28. U.K MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 29. U.K MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION)

TABLE 30. U.K MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 31. FRANCE MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 32. FRANCE MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION)

TABLE 33. FRANCE MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 34. ITALY MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 35. ITALY MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION)

TABLE 36. ITALY MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 37. SPAIN MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 38. SPAIN MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION)

TABLE 39. SPAIN MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 40. ROE MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 41. ROE MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION)

TABLE 42. ROE MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 43. ASIA PACIFC MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 44. ASIA PACIFC MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 45. ASIA PACIFC MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION)

TABLE 46. ASIA PACIFC MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 47. CHINA MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 48. CHINA MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION)

TABLE 49. CHINA MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 50. INDIA MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 51. INDIA MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION)

TABLE 52. INDIA MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 53. JAPAN MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 54. JAPAN MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION)

TABLE 55. JAPAN MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 56. REST OF APAC MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 57. REST OF APAC MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION)

TABLE 58. REST OF APAC MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 59. REST OF WORLD MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 60. REST OF WORLD MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY TREATMENT, 2021-2027 (USD BILLION)

TABLE 61. REST OF WORLD MENSTRUAL CRAMPS TREATMENT MARKET VALUE, BY DISTRIBUTION CHANNEL, 2021-2027 (USD BILLION)

TABLE 62. ABBVIE INC.: FINANCIALS

TABLE 63. ABBVIE INC.: PRODUCTS & SERVICES

TABLE 64. ABBVIE INC.: RECENT DEVELOPMENTS

TABLE 65. TORRENT PHARMACEUTICALS LTD.: FINANCIALS

TABLE 66. TORRENT PHARMACEUTICALS LTD.: PRODUCTS & SERVICES

TABLE 67. TORRENT PHARMACEUTICALS LTD.: RECENT DEVELOPMENTS

TABLE 68. SUN PHARMACEUTICAL INDUSTRIES LTD.: FINANCIALS

TABLE 69. SUN PHARMACEUTICAL INDUSTRIES LTD.: PRODUCTS & SERVICES

TABLE 70. SUN PHARMACEUTICAL INDUSTRIES LTD.: RECENT DEVELOPMENTS

TABLE 71. DR. REDDY’S LABORATORIES LTD.: FINANCIALS

TABLE 72. DR. REDDY’S LABORATORIES LTD.: PRODUCTS & SERVICES

TABLE 73. DR. REDDY’S LABORATORIES LTD.: RECENT DEVELOPMENTS

TABLE 74. JOHNSON AND JOHNSON: FINANCIALS

TABLE 75. JOHNSON AND JOHNSON: PRODUCTS & SERVICES

TABLE 76. JOHNSON AND JOHNSON: RECENT DEVELOPMENTS

TABLE 77. BAYER AG: FINANCIALS

TABLE 78. BAYER AG: PRODUCTS & SERVICES

TABLE 79. BAYER AG: RECENT DEVELOPMENTS

TABLE 80. TAJ PHARMACEUTICALS LIMITED: FINANCIALS

TABLE 81. TAJ PHARMACEUTICALS LIMITED: PRODUCTS & SERVICES

TABLE 82. TAJ PHARMACEUTICALS LIMITED: RECENT DEVELOPMENTS

TABLE 83. ABBOTT LABORATORIES: FINANCIALS

TABLE 84. ABBOTT LABORATORIES: PRODUCTS & SERVICES

TABLE 85. ABBOTT LABORATORIES: RECENT DEVELOPMENTS

TABLE 86. PFIZER INC.: FINANCIALS

TABLE 87. PFIZER INC.: PRODUCTS & SERVICES

TABLE 88. PFIZER INC.: RECENT DEVELOPMENTS

TABLE 89. GLAXOSMITHKLINE PLC: FINANCIALS

TABLE 90. GLAXOSMITHKLINE PLC: PRODUCTS & SERVICES

TABLE 91. GLAXOSMITHKLINE PLC: RECENT DEVELOPMENTS